The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

My Husband is Planning His Bachelor Party. I’m Not Sure How He’ll Take My Thoughts on the Matter.

The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...

Ophthalmologists must take measures to avoid misdiagnosing age-related macular degeneration and consider mimics of the ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Once you’ve determined that a new freckle is harmless, it’s time to prevent and treat it through your at-home skin-care regimen. Below, dermatologists walk us through how to get rid of dark ...

including for the potential treatment of Ataxia-Telangiectasia (A-T) and other potential indications; the strategic development path for EryDex; planned regulatory agency submissions and clinical ...

Open label extension initiated with 17 participants rolling over to date in the U.S., U.K., and European Union. Participants ...

Mary Kay Koenig from UTHealth Houston with a discussion focused on addressing the high unmet need in Ataxia-Telangiectasia ... detail current symptomatic treatment approaches for patients with ...

Ataxia-Telangiectasia (A-T), today, Friday, February 7, 2025, beginning at 10:00 a.m. Eastern Time. The webinar will feature leading A-T KOL Mary Kay Koenig, M.D., who will: 1) provide an A-T natural ...

Macular telangiectasia type 2 (MacTel ... in ellipsoid zone area loss from baseline to month 24. Findings showed treatment with revakinagene taroretcel statistically significantly reduced the ...